118 related articles for article (PubMed ID: 18626384)
1. Management of a complex scalp defect.
Plast Reconstr Surg; 2008 Aug; 122(2):623-625. PubMed ID: 18626384
[No Abstract] [Full Text] [Related]
2. Discussion: Management of a complex scalp defect.
Serletti JM
Plast Reconstr Surg; 2008 Aug; 122(2):626-629. PubMed ID: 18626385
[No Abstract] [Full Text] [Related]
3. Impact of bevacizumab chemotherapy on craniotomy wound healing.
Clark AJ; Butowski NA; Chang SM; Prados MD; Clarke J; Polley MY; Sughrue ME; McDermott MW; Parsa AT; Berger MS; Aghi MK
J Neurosurg; 2011 Jun; 114(6):1609-16. PubMed ID: 21142749
[TBL] [Abstract][Full Text] [Related]
4. Extremely late wound dehiscence following bevazicumab treatment in a long term survival glioblastoma patient.
Laviv Y; Rappaport ZH
Clin Neurol Neurosurg; 2014 Dec; 127():125-7. PubMed ID: 25459258
[No Abstract] [Full Text] [Related]
5. Surgical management of radiated scalp in patients with recurrent glioma.
Nair S; Giannakopoulos G; Granick M; Solomon M; McCormack T; Black P
Neurosurgery; 1994 Jan; 34(1):103-6; discussion 106-7. PubMed ID: 8121546
[TBL] [Abstract][Full Text] [Related]
6. Indication for repeat surgery of glioblastoma: influence of progress of disease.
Mühling M; Krage J; Hussein S; Samii M
Front Radiat Ther Oncol; 1999; 33():192-201. PubMed ID: 10549489
[No Abstract] [Full Text] [Related]
7. Microsurgical scalp and skull reconstruction using a serratus anterior myo-osseous flap.
Ueda K; Harashina T; Inoue T; Tanaka I; Harada T
Ann Plast Surg; 1993 Jul; 31(1):10-4. PubMed ID: 8357214
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab and irinotecan therapy in glioblastoma multiforme: a series of 13 cases.
Ali SA; McHayleh WM; Ahmad A; Sehgal R; Braffet M; Rahman M; Bejjani G; Friedland DM
J Neurosurg; 2008 Aug; 109(2):268-72. PubMed ID: 18671639
[TBL] [Abstract][Full Text] [Related]
9. [Malignant gliomas--radiotherapy].
Schratter-Sehn A
Wien Med Wochenschr; 2006 Jun; 156(11-12):342-5. PubMed ID: 16944365
[TBL] [Abstract][Full Text] [Related]
10. Advantages and Disadvantages of Combined Chemotherapy with Carmustine Wafer and Bevacizumab in Patients with Newly Diagnosed Glioblastoma: A Single-Institutional Experience.
Akiyama Y; Kimura Y; Enatsu R; Mikami T; Wanibuchi M; Mikuni N
World Neurosurg; 2018 May; 113():e508-e514. PubMed ID: 29476996
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab as a treatment option for radiation-induced cerebral necrosis.
Matuschek C; Bölke E; Nawatny J; Hoffmann TK; Peiper M; Orth K; Gerber PA; Rusnak E; Lammering G; Budach W
Strahlenther Onkol; 2011 Feb; 187(2):135-9. PubMed ID: 21336713
[TBL] [Abstract][Full Text] [Related]
12. Ganglioglioma occurring with glioblastoma multiforme: separate lesions or the same lesion?
Stevens QE; Howes G; Dickerman RD; Lee JM; Nardone EM
Clin Neurol Neurosurg; 2007 Feb; 109(2):195-9. PubMed ID: 17056178
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma multiforme.
Cabrera AR; Cuneo KC; Vredenburgh JJ; Sampson JH; Kirkpatrick JP
J Natl Compr Canc Netw; 2012 Jun; 10(6):695-9. PubMed ID: 22679114
[TBL] [Abstract][Full Text] [Related]
14. Recurrent scalp metastasis from glioblastoma following resection.
Ginat DT; Kelly HR; Schaefer PW; Davidson CJ; Curry W
Clin Neurol Neurosurg; 2013 Apr; 115(4):461-3. PubMed ID: 22727368
[No Abstract] [Full Text] [Related]
15. Recent therapeutic advances and insights of recurrent glioblastoma multiforme.
Chen J; Xu T
Front Biosci (Landmark Ed); 2013 Jan; 18(2):676-84. PubMed ID: 23276952
[TBL] [Abstract][Full Text] [Related]
16. The added value of bevacizumab concomitantly administered with carboplatin versus carboplatin alone in patients with recurrent glioblastomas.
Kaloshi G; Diamandi P; Cakani B; Brace G; Rroji A; Petrela M
Tumori; 2015; 101(1):41-5. PubMed ID: 25702676
[TBL] [Abstract][Full Text] [Related]
17. Optic neuropathy in patients with glioblastoma receiving bevacizumab.
Sherman JH; Aregawi DG; Lai A; Fathallah-Shaykh HM; Bierman PJ; Linsky K; Larner JM; Newman SA; Schiff D
Neurology; 2009 Dec; 73(22):1924-6. PubMed ID: 19949039
[No Abstract] [Full Text] [Related]
18. Bevacizumab plus irinotecan in recurrent glioblastoma.
Chamberlain MC
J Clin Oncol; 2008 Feb; 26(6):1012-3; author reply 1013. PubMed ID: 18281677
[No Abstract] [Full Text] [Related]
19. [Bevacizumab (Avastin) related surgical complications: comment to Abbrederis K et al. (2007)].
Lordick F; Siewert JR
Chirurg; 2008 Apr; 79(4):356-60. PubMed ID: 17453166
[No Abstract] [Full Text] [Related]
20. Prophylactic plastic surgery closure of neurosurgical scalp incisions reduces the incidence of wound complications in previously-operated patients treated with bevacizumab (Avastin®) and radiation.
Golas AR; Boyko T; Schwartz TH; Stieg PE; Boockvar JA; Spector JA
J Neurooncol; 2014 Sep; 119(2):327-31. PubMed ID: 24872117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
